Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mammography advisory committee

This article was originally published in The Gray Sheet

Executive Summary

FDA National Mammography Quality Assurance Advisory Committee will convene April 19 to discuss whether images from reconstructed, compressed digital data, and digitized film-screen mammograms can be used for primary interpretation or storage. CDRH Director David Feigal touched on the issue at a recent oncology meeting: "As we increasingly use telemedicine and data compression techniques to be able to squeeze data-dense images into telephone lines or high-speed lines and open them back up on a remote computer," FDA needs to ensure that information is not altered or lost. The committee also will address ways to reduce regulatory burdens for MQSA facilities and discuss revisions to the compliance guide...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT019834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel